ArticleJournal of experimental & clinical cancer research : CR2020

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.

Sean P Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.